The Veterinary Medicine Advisory Committee will meet March 24 in Rockville, Md., to discuss the Risk Minimization Act Plan (RiskMAP) for ProHeart 6. The RiskMAP goal is to manage the re-introduction of ProHeart 6 to ensure its safe, appropriate use for heartworm protection while minimizing the risk to dogs. Fort Dodge Animal Health voluntarily recalled ProHeart 6 in September 2004 to address federal safety concerns. The Food and Drug Administration's Center for Veterinary Medicine will present the FDA’s analysis of 18 months of information collected under the RiskMAP and will seek feedback from a panel of experts. The meeting is open to the public. Oral or written data, information and views can be presented. Written statements may be sent by March 17 to Aleta Sindelar, CVM, (HFV-3), 7519 Standish Place, Rockville, MD 20855. Oral presentations from the public are set for 1 to 2 p.m. March 24. Interested persons must notify Sindelar by March 9. The meeting is scheduled from 8:30 a.m. to 5 p.m. at the Rockville Hilton.
